• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高倍体和 11 号染色体的反复缺失是生长激素细胞垂体肿瘤的重要特征。

High level of aneuploidy and recurrent loss of chromosome 11 as relevant features of somatotroph pituitary tumors.

机构信息

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

出版信息

J Transl Med. 2024 Nov 4;22(1):994. doi: 10.1186/s12967-024-05736-0.

DOI:10.1186/s12967-024-05736-0
PMID:39497133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11536836/
Abstract

BACKGROUND

Somatotroph neuroendocrine pituitary tumors (sPitNET) are a subtype of pituitary tumors that commonly cause acromegaly. Our study aimed to determine the spectrum of DNA copy number abnormalities (CNAs) in sPitNETs and their relevance.

METHODS

A landscape of CNAs in sPitNETs was determined using combined whole-genome approaches involving low-pass whole genome sequencing and SNP microarrays. Fluorescent in situ hybridization (FISH) was used for microscopic validation of CNAs. The tumors were also subjected to transcriptome and DNA methylation analyses with RNAseq and microarrays, respectively.

RESULTS

We observed a wide spectrum of cytogenetic changes ranging from multiple deletions, recurrent chromosome 11 loss, stable genomes, to duplication of the majority of the chromosomes. The identified CNAs were confirmed with FISH. sPitNETs with multiple duplications were characterized by intratumoral heterogeneity in chromosome number variation in individual tumor cells, as determined with FISH. These tumors were separate CNA-related sPitNET subtype in clustering analyses with CNA signature specific for whole genome doubling-related etiology. This subtype encompassed GNAS-wild type, mostly densely granulated tumors with favorable expression level of known prognosis-related genes, notably enriched with POUF1/NR5A1-double positive PitNETs. Chromosomal deletions in sPitNETs are functionally relevant. They occurred in gene-dense DNA regions and were related to genes downregulation and increased DNA methylation in the CpG island and promoter regions in the affected regions. Recurrent loss of chromosome 11 was reflected by lowered MEN1 and AIP. No such unequivocal relevance was found for chromosomal gains. Comparisons of transcriptomes of selected most cytogenetically stable sPitNETs with tumors with recurrent loss of chromosome 11 showed upregulation of processes related to gene dosage compensation mechanism in tumors with deletion. Comparison of stable tumors with those with multiple duplications showed upregulation of processes related to mitotic spindle, DNA repair, and chromatin organization. Both comparisons showed upregulation of the processes related to immune infiltration in cytogenetically stable tumors and deconvolution of DNA methylation data indicated a higher content of specified immune cells and lower tumor purity in these tumors.

CONCLUSIONS

sPitNETs fall into three relevant cytogenetic groups: highly aneuploid tumors characterized by known prognostically favorable features and low aneuploidy tumors including specific subtype with chromosome 11 loss.

摘要

背景

生长激素细胞神经内分泌垂体肿瘤(sPitNET)是一种常见引起肢端肥大症的垂体肿瘤亚型。我们的研究旨在确定 sPitNET 中 DNA 拷贝数异常(CNAs)的图谱及其相关性。

方法

采用低通全基因组测序和 SNP 微阵列相结合的全基因组方法,确定 sPitNET 中的 CNA 图谱。使用荧光原位杂交(FISH)对 CNA 进行微观验证。肿瘤还分别进行了转录组和 DNA 甲基化分析,分别使用 RNAseq 和微阵列。

结果

我们观察到广泛的细胞遗传学变化,从多个缺失、染色体 11 反复丢失、稳定的基因组到大多数染色体的重复。用 FISH 验证了所鉴定的 CNA。用 FISH 检测到,具有多个重复的 sPitNET 肿瘤细胞内存在肿瘤内染色体数目变异的异质性。这些肿瘤在聚类分析中是单独的与 CNA 相关的 sPitNET 亚型,具有全基因组倍增相关病因的 CNA 特征。这种亚型包含 GNAS 野生型,主要是密集颗粒状肿瘤,具有已知预后相关基因的有利表达水平,特别是富含 POUF1/NR5A1-双阳性 PitNET。sPitNET 中的染色体缺失具有功能相关性。它们发生在基因密集的 DNA 区域,与受影响区域中基因下调和 CpG 岛和启动子区域的 DNA 甲基化增加有关。染色体 11 的反复丢失反映了 MEN1 和 AIP 的降低。对于染色体获得,没有发现如此明确的相关性。对选定的大多数细胞遗传学稳定的 sPitNET 肿瘤与反复染色体 11 缺失的肿瘤进行转录组比较显示,缺失肿瘤中与基因剂量补偿机制相关的过程上调。稳定肿瘤与多个重复肿瘤的比较显示,有丝分裂纺锤体、DNA 修复和染色质组织相关过程上调。这两个比较都显示出细胞遗传学稳定肿瘤中与免疫浸润相关的过程上调,并且去卷积 DNA 甲基化数据表明这些肿瘤中特定免疫细胞含量较高,肿瘤纯度较低。

结论

sPitNET 分为三个相关的细胞遗传学组:以已知预后良好特征为特征的高度非整倍体肿瘤和包括具有染色体 11 缺失的特定亚型的低度非整倍体肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/e3ac1b35534a/12967_2024_5736_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/8e1b72abffe3/12967_2024_5736_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/8ed619d63eec/12967_2024_5736_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/f6fc06cc55ae/12967_2024_5736_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/bb1af228013a/12967_2024_5736_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/119837416078/12967_2024_5736_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/f6a46d6b5b87/12967_2024_5736_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/e3ac1b35534a/12967_2024_5736_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/8e1b72abffe3/12967_2024_5736_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/8ed619d63eec/12967_2024_5736_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/f6fc06cc55ae/12967_2024_5736_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/bb1af228013a/12967_2024_5736_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/119837416078/12967_2024_5736_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/f6a46d6b5b87/12967_2024_5736_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/139e/11536836/e3ac1b35534a/12967_2024_5736_Fig2_HTML.jpg

相似文献

1
High level of aneuploidy and recurrent loss of chromosome 11 as relevant features of somatotroph pituitary tumors.高倍体和 11 号染色体的反复缺失是生长激素细胞垂体肿瘤的重要特征。
J Transl Med. 2024 Nov 4;22(1):994. doi: 10.1186/s12967-024-05736-0.
2
DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.生长激素细胞垂体神经内分泌肿瘤中的 DNA 甲基化模式。
Neuroendocrinology. 2024;114(1):51-63. doi: 10.1159/000533692. Epub 2023 Sep 12.
3
Genetic and Epigenetic Characterization of Growth Hormone-Secreting Pituitary Tumors.生长激素分泌性垂体肿瘤的遗传和表观遗传学特征。
Mol Cancer Res. 2019 Dec;17(12):2432-2443. doi: 10.1158/1541-7786.MCR-19-0434. Epub 2019 Oct 2.
4
Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.散发型 GH 分泌性垂体腺瘤中的基因组改变和复杂的亚克隆结构。
J Clin Endocrinol Metab. 2018 May 1;103(5):1929-1939. doi: 10.1210/jc.2017-02287.
5
The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.垂体腺瘤的表观基因组景观揭示了特定的改变,并在肢端肥大症、库欣病和内分泌非活跃亚型之间进行了区分。
Clin Cancer Res. 2018 Sep 1;24(17):4126-4136. doi: 10.1158/1078-0432.CCR-17-2206. Epub 2018 Jul 3.
6
Molecular cytogenetics of chromosome 11 in pituitary adenomas: a comparison of fluorescence in situ hybridization and DNA ploidy study.垂体腺瘤中11号染色体的分子细胞遗传学:荧光原位杂交与DNA倍体研究的比较
Hum Pathol. 1999 Nov;30(11):1377-82. doi: 10.1016/s0046-8177(99)90072-2.
7
Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.导致肢端肥大症的垂体神经内分泌肿瘤的转录组分类。
Cells. 2022 Nov 30;11(23):3846. doi: 10.3390/cells11233846.
8
Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.染色体不稳定性在垂体神经内分泌肿瘤预后预测中的作用。
Acta Neuropathol Commun. 2020 Nov 10;8(1):190. doi: 10.1186/s40478-020-01067-5.
9
Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.通过阵列比较基因组杂交确定小肠神经内分泌肿瘤中的拷贝数改变。
BMC Cancer. 2013 Oct 29;13:505. doi: 10.1186/1471-2407-13-505.
10
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.同步发生的不同细胞谱系的垂体神经内分泌肿瘤。
Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.

引用本文的文献

1
PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective.肢端肥大症患者中PIT-1/SF-1阳性垂体瘤:转录组学视角
Acta Neuropathol Commun. 2025 Aug 14;13(1):174. doi: 10.1186/s40478-025-02091-z.
2
Pivotal role of biallelic frequency analysis in identifying copy number alterations using genome-wide methods in tumors with a high level of aneuploidy.双等位基因频率分析在使用全基因组方法识别高度非整倍体肿瘤中的拷贝数改变中的关键作用。
J Appl Genet. 2025 Mar 4. doi: 10.1007/s13353-025-00951-x.

本文引用的文献

1
Methods for constructing and evaluating consensus genomic interval sets.构建和评估共识基因组区间集的方法。
Nucleic Acids Res. 2024 Sep 23;52(17):10119-10131. doi: 10.1093/nar/gkae685.
2
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.全基因组杂合性缺失预测垂体神经内分泌肿瘤侵袭性和治疗抵抗行为。
Acta Neuropathol. 2024 May 17;147(1):85. doi: 10.1007/s00401-024-02736-8.
3
Aneuploidy and complex genomic rearrangements in cancer evolution.癌症进化中的非整倍体和复杂基因组重排。
Nat Cancer. 2024 Feb;5(2):228-239. doi: 10.1038/s43018-023-00711-y. Epub 2024 Jan 29.
4
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.具有PIT1/SF1共表达的垂体神经内分泌肿瘤表现出独特的临床病理和分子特征。
Acta Neuropathol. 2024 Jan 16;147(1):16. doi: 10.1007/s00401-024-02686-1.
5
Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer.基因剂量补偿:起源、鉴定补偿基因的标准以及机制,包括作为癌症中新兴系统水平特性的传感器环。
Cancer Med. 2023 Dec;12(24):22130-22155. doi: 10.1002/cam4.6719. Epub 2023 Nov 21.
6
Clinical Implications of Pituitary Adenomas Exhibiting Dual Transcription Factor Staining: A Case Series of 27 Patients.表现为双重转录因子染色的垂体腺瘤的临床意义:27 例患者的病例系列。
World Neurosurg. 2024 Feb;182:e62-e66. doi: 10.1016/j.wneu.2023.11.036. Epub 2023 Nov 14.
7
Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly.肢端肥大症中肿瘤侵袭与生长抑素受体亚型的相关性。
J Neurosurg. 2023 Oct 6;140(4):1019-1028. doi: 10.3171/2023.7.JNS23858. Print 2024 Apr 1.
8
DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.生长激素细胞垂体神经内分泌肿瘤中的 DNA 甲基化模式。
Neuroendocrinology. 2024;114(1):51-63. doi: 10.1159/000533692. Epub 2023 Sep 12.
9
Sporadic pituitary adenoma with somatic double-hit loss of MEN1.散发性垂体腺瘤伴 MEN1 种系双打击缺失。
Pituitary. 2023 Aug;26(4):488-494. doi: 10.1007/s11102-023-01336-1. Epub 2023 Jul 13.
10
Genome doubling perturbs DNA packing and promotes cancer development.基因组加倍扰乱DNA包装并促进癌症发展。
Nature. 2023 Mar 15. doi: 10.1038/d41586-023-00426-1.